Sunshine Historical Income Statement
| SBFM Stock | USD 2.86 0.13 4.76% |
Historical analysis of Sunshine Biopharma income statement accounts such as Selling General Administrative of 10.6 M, Selling And Marketing Expenses of 771 K, Total Other Income Expense Net of 708.1 K or Research Development of 1.9 M can show how well Sunshine Biopharma performed in making a profits. Evaluating Sunshine Biopharma income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sunshine Biopharma's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Sunshine Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sunshine Biopharma is a good buy for the upcoming year.
Sunshine |
About Sunshine Income Statement Analysis
Sunshine Biopharma Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sunshine Biopharma shareholders. The income statement also shows Sunshine investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Sunshine Biopharma Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sunshine Biopharma. It is also known as Sunshine Biopharma overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Sunshine Biopharma's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sunshine Biopharma current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.At this time, Sunshine Biopharma's Total Other Income Expense Net is very stable compared to the past year. As of the 29th of November 2024, Research Development is likely to grow to about 1.9 M, while EBIT is likely to drop (4.2 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Operating Expenses | 2.7M | 13.0M | 28.9M | 30.3M | Interest Expense | 328.8K | 39.4K | 137.3K | 148.9K |
Sunshine Biopharma income statement Correlations
Click cells to compare fundamentals
Sunshine Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sunshine Biopharma income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 115.9K | 168.1K | 328.8K | 39.4K | 137.3K | 148.9K | |
| Other Operating Expenses | 662.8K | 648.3K | 2.7M | 13.0M | 28.9M | 30.3M | |
| Operating Income | (641.6K) | (576.9K) | (2.4M) | (8.7M) | (4.8M) | (4.5M) | |
| Ebit | (641.6K) | (2.6M) | (12.1M) | (26.5M) | (4.0M) | (4.2M) | |
| Ebitda | (942.6K) | (2.6M) | (12.1M) | (26.4M) | (3.8M) | (4.0M) | |
| Total Operating Expenses | 651.7K | 622.4K | 2.6M | 10.4M | 13.1M | 13.8M | |
| Income Before Tax | (1.1M) | (2.8M) | (12.4M) | (26.5M) | (4.1M) | (4.3M) | |
| Net Income | (1.5M) | (897.7K) | (12.8M) | (26.7M) | (4.5M) | (4.7M) | |
| Income Tax Expense | 383.4K | (1.9M) | 328.8K | 233.3K | 395.2K | 414.9K | |
| Selling General Administrative | 622.7K | 547.4K | 1.9M | 8.9M | 10.1M | 10.6M | |
| Total Other Income Expense Net | (436.4K) | (2.2M) | (10.0M) | 489.6K | 674.4K | 708.1K | |
| Research Development | 15.2K | 60.9K | 672.2K | 811.9K | 1.9M | 1.9M | |
| Total Revenue | 21.1K | 71.4K | 228.4K | 4.3M | 24.1M | 25.3M | |
| Gross Profit | 10.1K | 45.6K | 110.6K | 1.7M | 8.3M | 8.8M | |
| Net Income From Continuing Ops | (1.1M) | (2.8M) | (12.4M) | (26.7M) | (26.8M) | (25.4M) | |
| Cost Of Revenue | 11.1K | 25.8K | 117.8K | 2.6M | 15.8M | 16.5M | |
| Net Income Applicable To Common Shares | (1.7M) | (2.8M) | (12.4M) | (26.7M) | (24.1M) | (22.9M) | |
| Depreciation And Amortization | (301.0K) | 14.1K | 12.7K | 25.2K | 149.1K | 156.6K | |
| Net Interest Income | (115.9K) | (168.1K) | (328.8K) | 479.2K | 602.3K | 632.4K | |
| Reconciled Depreciation | 13.8K | 14.1K | 12.7K | 25.2K | 125.8K | 132.1K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Sunshine Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. To learn how to invest in Sunshine Stock, please use our How to Invest in Sunshine Biopharma guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sunshine Biopharma. If investors know Sunshine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sunshine Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (127.90) | Revenue Per Share 197.42 | Quarterly Revenue Growth 0.416 | Return On Assets (0.11) | Return On Equity (0.18) |
The market value of Sunshine Biopharma is measured differently than its book value, which is the value of Sunshine that is recorded on the company's balance sheet. Investors also form their own opinion of Sunshine Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sunshine Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sunshine Biopharma's market value can be influenced by many factors that don't directly affect Sunshine Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sunshine Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sunshine Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sunshine Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.